BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4102007)

  • 21. Experience with large-dose intravenous antithymocyte globulin in primates and man.
    Cosimi AB; Skamene E; Bonney WW; Russell PS
    Surgery; 1970 Jul; 68(1):54-61. PubMed ID: 4193070
    [No Abstract]   [Full Text] [Related]  

  • 22. Sex difference in specific and non-specific suppression of non-H-2 allograft responsiveness in mice.
    Nĕmec M
    Folia Biol (Praha); 1971; 17(4):220-6. PubMed ID: 4943668
    [No Abstract]   [Full Text] [Related]  

  • 23. Gamma globulin fragments in urine of kidney transplant patients in relation to rejection crisis.
    Hermann G; Zühlke V; Faul P
    Eur Surg Res; 1970; 2(1):55-63. PubMed ID: 4131420
    [No Abstract]   [Full Text] [Related]  

  • 24. [Inhibition of homologous disease in adult F1 hybrid mice by treatment of donor and recipient animals with rabbit gamma-globulins].
    LIACOPOULOS P; STIFFEL C
    Rev Fr Etud Clin Biol; 1963; 8():587-9. PubMed ID: 13930416
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of 6-mercaptopurine-rabbit-anti-mouse lymphocyte globulin on the survival of skin allografts in mice.
    Hilgert I; Malberg K; Matthes K; Ambrosius H
    Folia Biol (Praha); 1982; 28(1):22-7. PubMed ID: 7040118
    [No Abstract]   [Full Text] [Related]  

  • 26. Rabbit anti-rat lymphocyte serum: relationship between dosages, circulating lymphocytes, and the primary immune response.
    Rule AH; Judd KP
    Transplantation; 1968 Dec; 6(9):970-6. PubMed ID: 4177515
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of horse anti-dog antilymphocyte globulin in the treatment of hepatic allografts.
    Birtch AG; Orr WM; Duquella J
    Surg Forum; 1968; 19():186-8. PubMed ID: 4887904
    [No Abstract]   [Full Text] [Related]  

  • 28. Prolongation of rat renal allograft survival by chicken antirat lymphocyte globulin.
    Morris RE; Enomoto K; Kay GL; Dong E; Shumway NE
    Transplant Proc; 1973 Mar; 5(1):535-40. PubMed ID: 4121178
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion.
    Wood ML; Heppner G; Gozzo JJ; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):691-6. PubMed ID: 4572128
    [No Abstract]   [Full Text] [Related]  

  • 30. Cytology and histology of haemopoietic cell transplantation under the influence of ALS in mice. II. The effect of marrow from donors pretreated with antilymphocyte serum (ALS) on the recipient.
    Thierfelder S; Rodriguez-Paradisi E; Mempel W; Beil E
    Clin Exp Immunol; 1971 Jan; 8(1):121-9. PubMed ID: 4395674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The double barrier in bone marrow transplantation.
    van Bekkum DW
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract]   [Full Text] [Related]  

  • 32. Mouse immunoglobulin allotypes: detection with rabbit antiserums.
    Coe JE
    Science; 1967 Feb; 155(3762):562 passim. PubMed ID: 4163015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological protection of rabbit corneal allografts. Survival of corneas pretreated with succinylated antilymphocyte globulin.
    Chandler JW; Gebbhardt BM; Sugar J; Kaufman HE
    Transplantation; 1974 Jan; 17(1):146-8. PubMed ID: 4588153
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum.
    Storb R; Floersheim GL; Weiden PL; Graham TC; Kolb HJ; Lerner KG; Schroeder ML; Thomas ED
    J Immunol; 1974 Apr; 112(4):1508-16. PubMed ID: 4592604
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts.
    Kashiwagi N; Brantigan CO; Brettschneider L; Groth CG; Starzl TE
    Ann Intern Med; 1968 Feb; 68(2):275-86. PubMed ID: 4181614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the decline in immunosuppressive potency of rabbit anti-mouse thymocyte sera raised by repeated immunization of the same rabbit.
    Ponsford FM; Symes MO
    Folia Biol (Praha); 1971; 17(4):227-35. PubMed ID: 5002373
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on rabbit lymphocytes in vitro. 13. The induction of blast transformation with the F (ab')2 and Fab fragments of anti-lymphocytic, anti-IgG and anti-allotypic globulins.
    Sell S; Mascari RA; Hughes SJ
    J Immunol; 1970 Dec; 105(6):1400-5. PubMed ID: 4098501
    [No Abstract]   [Full Text] [Related]  

  • 39. [The effect of a rabbit anti-mouse lymphocyte serum on the survival time of allogenous skin].
    Biege G; von Broen B
    Acta Biol Med Ger; 1969; 22(2):423-6. PubMed ID: 4903489
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of low doses of homozygous allogeneic bone marrow cells to induce tolerance with antilymphocyte serum (ALS): tolerance by intraorgan injection.
    Monaco AP; Gozzo JJ; Wood ML; Liegeois A
    Transplant Proc; 1971 Mar; 3(1):680-3. PubMed ID: 4398509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.